UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BRAF-mutated cells activate GCN2-mediated integrated stress response as a cytoprotective mechanism in response to vemurafenib

Biochemical and biophysical research communications, 2017-01, Vol.482 (4), p.1491-1497

2017

Volltextzugriff (PDF)

Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation

Scientific reports, 2022-07, Vol.12 (1), p.11533-11533, Article 11533

2022

Volltextzugriff (PDF)

Estrogen‐mediated post transcriptional down‐regulation of P‐glycoprotein in MDR1‐transduced human breast cancer cells

Cancer science, 2006-11, Vol.97 (11), p.1198-1204

2006

Volltextzugriff (PDF)

Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.2092-2102

2007

Volltextzugriff (PDF)

Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (12), p.4346-4352

2004

Volltextzugriff (PDF)

Activating mutations in EGFR and PI3K promote ATF4 induction for NSCLC cell survival during amino acid deprivation

Heliyon, 2023-04, Vol.9 (4), p.e14799-e14799, Article e14799

2023

Volltextzugriff (PDF)

Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation

Cancer science, 2015-07, Vol.106 (7), p.909-920

2015

Volltextzugriff (PDF)

TBL2 is a novel PERK-binding protein that modulates stress-signaling and cell survival during endoplasmic reticulum stress

PloS one, 2014-11, Vol.9 (11), p.e112761-e112761

2014

Volltextzugriff (PDF)

Gefitinib reverses breast cancer resistance protein–mediated drug resistance

Molecular cancer therapeutics, 2004-09, Vol.3 (9), p.1119-1125

2004

Volltextzugriff (PDF)

Disrupting ATF4 Expression Mechanisms Provides an Effective Strategy for BRAF-Targeted Melanoma Therapy

iScience, 2020-04, Vol.23 (4), p.101028-101028, Article 101028

2020

Volltextzugriff (PDF)

Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens

Molecular pharmacology, 2003-09, Vol.64 (3), p.610-618

2003

Volltextzugriff (PDF)

Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics

Cancer science, 2005-08, Vol.96 (8), p.457-465

2005

Volltextzugriff (PDF)

Development of a gene expression database and related analysis programs for evaluation of anticancer compounds

Cancer science, 2013-03, Vol.104 (3), p.360-368

2013

Volltextzugriff (PDF)

Preventing the unfolded protein response via aberrant activation of 4E‐binding protein 1 by versipelostatin

Cancer science, 2009-02, Vol.100 (2), p.327-333

2009

Volltextzugriff (PDF)

Functional SNPs of the breast cancer resistance protein ‐ therapeutic effects and inhibitor development

Cancer letters, 2006-03, Vol.234 (1), p.73-80

2006

Volltextzugriff (PDF)

Estrone and 17β‐Estradiol Reverse Breast Cancer Resistance Protein‐mediated Multidrug Resistance

Cancer science, 2002-03, Vol.93 (3), p.231-235

2002

Volltextzugriff (PDF)

Hyperactivation of 4E-binding protein 1 as a mediator of biguanide-induced cytotoxicity during glucose deprivation

Molecular cancer therapeutics, 2012-05, Vol.11 (5), p.1082-1091

2012

Volltextzugriff (PDF)

Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants

International journal of cancer, 2003-12, Vol.107 (5), p.757-763

2003

Volltextzugriff (PDF)

eIF4B enhances ATF4 expression and contributes to cellular adaptation to asparagine limitation in BRAF-mutated A375 melanoma

Biochemical and biophysical research communications, 2021-10, Vol.573, p.93-99

2021

Volltextzugriff (PDF)

The identification of two germ-line mutations in the Human Breast Cancer Resistance Protein gene that result in the expression of a low/non-functional protein

Pharmaceutical research, 2007-06, Vol.24 (6), p.1108-1117

2007

Volltextzugriff (PDF)

A Novel Endoplasmic Reticulum Export Signal

The Journal of biological chemistry, 2009-10, Vol.284 (40), p.27500-27510

2009

Volltextzugriff (PDF)

Induction of stearoyl‐CoA desaturase confers cell density‐dependent ferroptosis resistance in melanoma

Journal of cellular biochemistry, 2024-04, Vol.125 (4), p.e30542-n/a

2024

Volltextzugriff (PDF)

Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients

Cancer science, 2007-10, Vol.98 (10), p.1609-1616

2007

Volltextzugriff (PDF)

PMEPA1, a TGF-β- and hypoxia-inducible gene that participates in hypoxic gene expression networks in solid tumors

Biochemical and biophysical research communications, 2016-10, Vol.479 (4), p.615-621

2016

Volltextzugriff (PDF)

InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment

Oncotarget, 2018-06, Vol.9 (49), p.29097-29111

2018

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(68)

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

BRAF-mutated cells activate GCN2-mediated integrated stress response as a cytoprotective mechanism in response to vemurafenib

Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation

Estrogen‐mediated post transcriptional down‐regulation of P‐glycoprotein in MDR1‐transduced human breast cancer cells

Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein

Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance

Activating mutations in EGFR and PI3K promote ATF4 induction for NSCLC cell survival during amino acid deprivation

Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation

TBL2 is a novel PERK-binding protein that modulates stress-signaling and cell survival during endoplasmic reticulum stress

Gefitinib reverses breast cancer resistance protein–mediated drug resistance

Disrupting ATF4 Expression Mechanisms Provides an Effective Strategy for BRAF-Targeted Melanoma Therapy

Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens

Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics

Development of a gene expression database and related analysis programs for evaluation of anticancer compounds

Preventing the unfolded protein response via aberrant activation of 4E‐binding protein 1 by versipelostatin

Functional SNPs of the breast cancer resistance protein ‐ therapeutic effects and inhibitor development

Estrone and 17β‐Estradiol Reverse Breast Cancer Resistance Protein‐mediated Multidrug Resistance

Hyperactivation of 4E-binding protein 1 as a mediator of biguanide-induced cytotoxicity during glucose deprivation

Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants

eIF4B enhances ATF4 expression and contributes to cellular adaptation to asparagine limitation in BRAF-mutated A375 melanoma

The identification of two germ-line mutations in the Human Breast Cancer Resistance Protein gene that result in the expression of a low/non-functional protein

A Novel Endoplasmic Reticulum Export Signal

Induction of stearoyl‐CoA desaturase confers cell density‐dependent ferroptosis resistance in melanoma

Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients

PMEPA1, a TGF-β- and hypoxia-inducible gene that participates in hypoxic gene expression networks in solid tumors

InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment

Suchergebnisse filtern